SMTL ID : 9ncw.2 (3 other biounits)

Crystal Structure of WDR5 in complex with Triazole-Based Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.58 Å

Oligo State

monomer

Ligands

1 x 01: 1-{[(6P)-3-[(3,5-dimethoxyphenyl)methyl]-6-(4-fluoro-2-methylphenyl)-4,5-dihydro-3H-naphtho[1,2-d][1,2,3]triazol-8-yl]methyl}-3-methyl-1,3-dihydro-2H-imidazol-2-imine

01.1: 21 residues within 4Å: Chain A: A.137, V.138, S.139, S.154, A.155, G.179, I.180, S.181, D.182, F.223, C.224, F.239, P.263, S.265, Y.281, K.349, Y.350, C.351, F.353, I.395, L.411 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:A.137, A:A.155, A:F.239, A:F.239, A:P.263, A:I.395, A:I.395, A:L.411 Hydrogen bonds: A:C.351, A:C.351 pi-Stacking: A:F.223, A:F.223, A:Y.281, A:Y.350 pi-Cation interactions: A:F.353

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Coker, J.A. et al., Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma. Biorxiv (2025)

Release Date

2025-08-13

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

WD repeat-containing protein 5

Related Entries With Identical Sequence